Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.

Bibert S, Guex N, Lourenco J, Brahier T, Papadimitriou-Olivgeris M, Damonti L, Manuel O, Liechti R, Götz L, Tschopp J, Quinodoz M, Vollenweider P, Pagani JL, Oddo M, Hügli O, Lamoth F, Erard V, Voide C, Delorenzi M, Rufer N, Candotti F, Rivolta C, Boillat-Blanco N, Bochud PY, RegCOVID Study Group

Open source

DOI: 10.3389/fimmu.2021.666163
Published: 2021
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2021.666163,
  title = {Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.},
  author = {Bibert S and Guex N and Lourenco J and Brahier T and Papadimitriou-Olivgeris M and Damonti L and Manuel O and Liechti R and Götz L and Tschopp J and Quinodoz M and Vollenweider P and Pagani JL and Oddo M and Hügli O and Lamoth F and Erard V and Voide C and Delorenzi M and Rufer N and Candotti F and Rivolta C and Boillat-Blanco N and Bochud PY and RegCOVID Study Group},
  year = {2021},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2021.666163},
  url = {https://doi.org/10.3389/fimmu.2021.666163}
}

RIS

TY  - JOUR
TI  - Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.
AU  - Bibert S
AU  - Guex N
AU  - Lourenco J
AU  - Brahier T
AU  - Papadimitriou-Olivgeris M
AU  - Damonti L
AU  - Manuel O
AU  - Liechti R
AU  - Götz L
AU  - Tschopp J
AU  - Quinodoz M
AU  - Vollenweider P
AU  - Pagani JL
AU  - Oddo M
AU  - Hügli O
AU  - Lamoth F
AU  - Erard V
AU  - Voide C
AU  - Delorenzi M
AU  - Rufer N
AU  - Candotti F
AU  - Rivolta C
AU  - Boillat-Blanco N
AU  - Bochud PY
AU  - RegCOVID Study Group
PY  - 2021
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2021.666163
UR  - https://doi.org/10.3389/fimmu.2021.666163
ER  -

APA

S, B., N, G., J, L., T, B., M, P., L, D., O, M., R, L., L, G., J, T., M, Q., P, V., JL, P., M, O., O, H., F, L., V, E., C, V., M, D., N, R., F, C., C, R., N, B., PY, B., & Group, R. S. (2021). Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2021.666163

Source records

pubmed · retrieved 2026-09-27T15:08:29.471Z